Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 91-100 of 114

Page
per page
  1. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  2. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  3. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  4. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  5. SGX-523
    A1196 SGX-523
     1 Citation
    Target: MET
    Summary: MET inibitor, highly selective, ATP-competitive
      ≥17.95 mg/mL
  6. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  7. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  8. Masitinib (AB1010)
    A2942 Masitinib (AB1010)
    Target: PDGFR|c-Kit|Lyn
    Summary: Tyrosine kinase inhibitor, potent and selective
      ≥24.95 mg/mL
  9. PRIMA-1
    A4483 PRIMA-1
    Target: p53
    Summary: BAX inhibitor
      ≥110.6 mg/mL
  10. PD168393
    A2024 PD168393
    Target: PDGFR|FGFR|EGFR|PKC|insulin
    Summary: EGFR inhibitor

Items 91-100 of 114

Page
per page
Shop By
Now Shopping by
  1. Related Disease Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 113item
  2. Natural Products 1 item
Specificity
  1. Selective 87item
Reversibility
  1. Reversible 2item
  2. Irreversible 4item
Target
  1. Caspases 2item
  2. Histone Deacetylases (HDACs) 15item
  3. Bcl-2 1 item
  4. PI3K 1 item
  5. Raf 2item
  6. Aurora Kinases 13item
  7. Bcl-xl 1 item
  8. CSF-1R 3item
  9. EZH2 2item
  10. Bromodomains 2item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. FLT3 4item
  14. LPA Receptors 1 item
  15. PLK 2item
  16. VEGFR 12item
  17. PDGFR 8item
  18. c-Kit 4item
  19. RET 1 item
  20. Bromodomain-containing proteins(BRDs) 1 item
  21. Mcl-1 1 item
  22. SGK 1 item
  23. DOT1L 1 item
  24. FGFR 7item
  25. Insulin-like growth factor receptors(IGFRs) 1 item
  26. Pim 2item
  27. Liver X receptors (LXRs) 1 item
  28. Sir2-like Family Deacetylases (Sirtuins) 1 item
  29. Deubiquitinating enzymes (DUBs) 1 item
  30. PP1 1 item
  31. PP2A 1 item
  32. Smoothened 1 item
  33. MET 1 item
  34. Src 1 item
  35. Trk Receptors 1 item
  36. STAT 3item
  37. EGFR 7item
  38. Hypoxia Inducible Factors (HIFs) 1 item
  39. JAK 5item
  40. DNA-PK 1 item
  41. HSP90 1 item
  42. Topoisomerases 1 item
  43. ErbB 3item
  44. Actin 1 item
  45. DNA Methyltransferases 3item
  46. ERK 1 item
  47. PKC 1 item
  48. CREBBP 1 item
  49. EP300 1 item
  50. Lyn 1 item
  51. HER2 1 item
  52. Insulin and Insulin-like Receptors 1 item
  53. PARP 1 item
  54. ALK 1 item
  55. Dehydrogenase 1 item
  56. Autophagy 2item
  57. Farnesyl Diphosphate Synthases 1 item
  58. MAGL 1 item
  59. Apoptosis Inducers 1 item
  60. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  61. Cytidine deaminases 1 item
  62. PP4 1 item
  63. VEGFR3/FLT4 1 item
  64. NTRK1/TRKA 1 item
  65. CSF-1R/c-Fms 1 item
  66. p53 2item
  67. HDAC 1 item
  68. insulin 1 item
  69. HDM2 ubiquitin ligase 1 item
  70. GLI 1 item
  71. Trx 1 item
  72. TYK2 1 item
  73. MUSK 1 item
  74. MAP3K 1 item
  75. RHA 1 item
Reported Experiments
  1. Animal Experiments 104item
  2. Cell Experiments 69item